Cell DeathAntineoplastic Combined Chemotherapy ProtocolsApoptosisCause of DeathChemotherapy, AdjuvantT-Lymphocytes, CytotoxicAntineoplastic AgentsCell SurvivalCaspasesDeathCell Line, TumorCisplatinDoxorubicinCaspase 3Combined Modality TherapyNecrosisProto-Oncogene Proteins c-bcl-2Treatment OutcomeCyclophosphamideDNA FragmentationTime FactorsMitochondriaSignal TransductionAutophagyCells, CulturedEtoposideNeoplasmsBreast NeoplasmsIn Situ Nick-End Labelingbcl-2-Associated X ProteinCell LineSurvival AnalysisCaspase InhibitorsReactive Oxygen SpeciesTumor Cells, CulturedDeath, Sudden, CardiacAntigens, CD95Dose-Response Relationship, DrugPrognosisSurvival RateLung NeoplasmsNeoadjuvant TherapyDrug Resistance, NeoplasmDisease-Free SurvivalAntineoplastic Agents, PhytogenicBrain DeathCytotoxicity, ImmunologicApoptosis Regulatory ProteinsNeoplasm StagingEnzyme ActivationPaclitaxelFas Ligand ProteinMice, Inbred C57BLPoly(ADP-ribose) PolymerasesDrug Administration ScheduleAmino Acid Chloromethyl KetonesNeuronsFlow CytometryCaspase 8Cytochromes cTumor Suppressor Protein p53MethotrexateCell ProliferationCaspase 9Blotting, WesternFollow-Up StudiesCysteine Proteinase InhibitorsDrug Screening Assays, AntitumorFetal Deathbcl-X ProteinVinblastineMutationEnzyme InhibitorsPore Forming Cytotoxic ProteinsCarboplatinDNA DamageMembrane Potential, MitochondrialTaxoidsProto-Oncogene ProteinsImmunohistochemistryAntimetabolites, AntineoplasticTransfectionAttitude to DeathCell CycleAntineoplastic Agents, AlkylatingCytotoxinsAntibiotics, AntineoplasticNeoplasm Recurrence, LocalCell DivisionMolecular Sequence DataHydrogen PeroxideRNA, Small InterferingDrug SynergismModels, BiologicalInduction ChemotherapyDeoxycytidineApoptosis Inducing FactorReceptors, Death DomainOrganoplatinum CompoundsProspective Studies